- $13.52m
- $8.01m
- $3.95m
- 27
- 14
- 48
- 19
Annual balance sheet for Geovax Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 9.88 | 11.4 | 27.6 | 6.45 | 5.51 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.183 | 0.049 | 0 | — | 0.659 |
Prepaid Expenses | |||||
Total Current Assets | 10.2 | 11.6 | 28.9 | 7.89 | 7.93 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.148 | 0.157 | 0.235 | 0.21 | 0.15 |
Other Long Term Assets | |||||
Total Assets | 10.4 | 11.8 | 31.3 | 9.28 | 8.16 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 0.81 | 5.44 | 4.75 | 3.52 | 3.11 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.825 | 7.44 | 4.75 | 3.52 | 3.11 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 9.57 | 4.36 | 26.6 | 5.76 | 5.05 |
Total Liabilities & Shareholders' Equity | 10.4 | 11.8 | 31.3 | 9.28 | 8.16 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |